Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP377976.RAYqRXFzNpQl40oB480ynO6BJtO-rOff6hYYDjnizhYGg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP377976.RAYqRXFzNpQl40oB480ynO6BJtO-rOff6hYYDjnizhYGg130_assertion type Assertion NP377976.RAYqRXFzNpQl40oB480ynO6BJtO-rOff6hYYDjnizhYGg130_head.
- NP377976.RAYqRXFzNpQl40oB480ynO6BJtO-rOff6hYYDjnizhYGg130_assertion description "[Erythropoietin (EPO) is of great interest as a therapy for many of the central nervous system (CNS) diseases and its administration is protective in experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis (MS).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP377976.RAYqRXFzNpQl40oB480ynO6BJtO-rOff6hYYDjnizhYGg130_provenance.
- NP377976.RAYqRXFzNpQl40oB480ynO6BJtO-rOff6hYYDjnizhYGg130_assertion evidence source_evidence_literature NP377976.RAYqRXFzNpQl40oB480ynO6BJtO-rOff6hYYDjnizhYGg130_provenance.
- NP377976.RAYqRXFzNpQl40oB480ynO6BJtO-rOff6hYYDjnizhYGg130_assertion SIO_000772 18670620 NP377976.RAYqRXFzNpQl40oB480ynO6BJtO-rOff6hYYDjnizhYGg130_provenance.
- NP377976.RAYqRXFzNpQl40oB480ynO6BJtO-rOff6hYYDjnizhYGg130_assertion wasDerivedFrom befree-20150227 NP377976.RAYqRXFzNpQl40oB480ynO6BJtO-rOff6hYYDjnizhYGg130_provenance.
- NP377976.RAYqRXFzNpQl40oB480ynO6BJtO-rOff6hYYDjnizhYGg130_assertion wasGeneratedBy ECO_0000203 NP377976.RAYqRXFzNpQl40oB480ynO6BJtO-rOff6hYYDjnizhYGg130_provenance.